Volta Medical

Volta Medical is a healthcare technology company that specializes in artificial intelligence solutions for interventional cardiac electrophysiology. Founded in 2016 by a data scientist and three electrophysiologists, the company focuses on enhancing the treatment of complex heart rhythm diseases through its advanced AI-driven software. The flagship product, VX1, is an AI-based medical device that assists physicians during cardiac ablation procedures, particularly for complex arrhythmias like atrial fibrillation. VX1 utilizes machine and deep learning algorithms to analyze intra-cardiac electrograms in real time, helping operators identify abnormal signals without altering their existing navigation systems or catheters. It is CE marked and FDA cleared, making it the first AI-based software solution approved by the FDA in the interventional cardiology field. Volta Medical operates internationally with over 130 employees across France, the United States, and Germany. The company collaborates with cardiac electrophysiologists and healthcare providers to improve procedural outcomes and patient care, supported by significant capital funding exceeding €90 million.

• Employees 100
• Founded 2016
• Annual Revenue $5100000
• Total Funding $68787390